Why Is Robotic Surgery-Focused Penny Stock Asensus Surgical Trading Higher On Friday?
Portfolio Pulse from Vandana Singh
KARL STORZ Endoscopy-America, Inc. has agreed to acquire Asensus Surgical Inc. (NYSE:ASXC) for $0.35 per share in cash, representing a significant premium. The transaction is expected to close in Q3 2024, after which Asensus will no longer be publicly traded.
June 07, 2024 | 4:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Asensus Surgical Inc. (NYSE:ASXC) is being acquired by KARL STORZ Endoscopy-America for $0.35 per share, a 67% premium. The deal is expected to close in Q3 2024, after which ASXC will no longer be publicly traded.
The acquisition at a significant premium is likely to drive ASXC's stock price up in the short term. The deal's approval and the expected closing in Q3 2024 provide a clear timeline for investors.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100